Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease

Table 2 Characteristics of the included studies within the meta-analysis of Ma et al[88]

Ref.	Sample size	Randomization	Blinding	Diagnostic method	Intervention	Duration	Follow-up
Aller et al[87]	28 (14/14)	Table of numbers	Double-blind	Histological	Lactobacillus bulgaricus and Streptococcus thermophilus vs placebo	3 mo	Yes
Vajro et al[90]	20 (10/10)	Yes	Double-blind	Radiological	Lactobacillus GG vs placebo	8 wk	Yes
Malaguarnera et al[91]	66 (34/32)	Computer generated	Double-blind	Histological	Bifidobacteriumlongum + Fos vs placebo	24 wk	Yes
Wong et al[92]	20 (10/10)	Computer generated	Double-blind	Histological	Lepicol probiotic and prebiotic formula vs nothing	6 mo	Yes